On September 22, 2023, James Huang resigned as Chairman and member of the board of directors of Alaunos Therapeutics, Inc. with immediate effect in order to focus on other business pursuits. Mr. Huang?s resignation was not the result of any disagreement on any matter relating to the Company?s operations, policies or practices. With Mr. Huang?s departure, the Board has elected Holger Weis as the Company?s new Chairman of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +13.79% | +17.86% | +24.47% |
Apr. 01 | Alaunos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | North American Morning Briefing : S&P 500 Futures -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.47% | 21.14M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- TCRT Stock
- News Alaunos Therapeutics, Inc.
- Alaunos Therapeutics, Inc. Announces Board Changes